Related Experiment Video
Updated: Dec 8, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Kawasaki-like disease in children with COVID-19
Ummusen Kaya Akca1, Selman Kesici2, Yasemin Ozsurekci3
1Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Insights
Children with COVID-19 may develop Kawasaki-like disease, often presenting atypically. Early recognition of these hyperinflammatory conditions is crucial for timely diagnosis and treatment of Coronavirus disease 2019 in pediatric patients.
Area of Science:
- Pediatric Infectious Diseases
- Cardiovascular Manifestations in Children
- Public Health & Epidemiology
Background:
- Coronavirus disease 2019 (COVID-19) has been associated with hyperinflammatory syndromes in children.
- Kawasaki disease (KD) and incomplete KD are recognized manifestations in pediatric COVID-19 cases.
- Atypical presentations of KD-like illness in children warrant investigation for COVID-19.
Observation:
- This study investigated four children with Kawasaki-like disease potentially linked to COVID-19.
- Three patients presented with features consistent with incomplete KD.
- Diagnostic challenges were noted, with mixed results from RT-PCR and serology for SARS-CoV-2.
Findings:
- A literature review identified 320 children with COVID-19-associated Kawasaki-like disease.
- SARS-CoV-2 RT-PCR was frequently negative (65.5%), while serology was often positive (83.8%).
- Treatment strategies included intravenous immunoglobulin (IVIG), corticosteroids, and anakinra, with most patients recovering.
Implications:
- Pediatric COVID-19 can manifest as atypical or incomplete Kawasaki-like disease.
- Healthcare providers must maintain a high index of suspicion for KD-like symptoms in children with COVID-19.
- Early diagnosis and appropriate management are essential to improve outcomes and prevent complications.
Abstract:
Children with Coronavirus disease 2019 (COVID-19) are being reported to have manifestations of hyperinflammatory states and/or Kawasaki-like disease. In this study, we investigated children with typical and atypical Kawasaki disease (KD) likely to be associated with COVID-19. We have reported four children with Kawasaki-like disease probably associated with COVID-19. The clinical features were consistent with incomplete KD in three patients. SARS-CoV-2 RT-PCR was positive in one and the serology was positive in one patient with negative RT-PCR. Corticosteroids, anakinra, intravenous immunoglobulin (IVIG), and acetylsalicylic acid were used in the treatment. Three patients recovered after the treatment while one patient died. The literature review revealed 36 articles describing 320 children with Kawasaki-like disease associated with COVID-19. SARS-CoV-2 RT-PCR was negative in 120 (65.5%) of 183 patients while the serology was positive in 130 (83.8%) of 155 patients. The therapeutic options have included IVIG, acetylsalicylic acid, tocilizumab, anakinra, enoxaparin, and methylprednisolone. Pediatric COVID-19 cases may present with atypical/incomplete Kawasaki-like disease. Thus, pediatricians need to be aware of such atypical presentations resembling KD for early diagnosis of COVID-19.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Myocarditis II: Clinical Features and Diagnostic Tests
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Kidney Disease II: Clinical Manifestations
